benefit from prophylactic treatments that mean added costs to health care while potentially incurring risk.
Methods
Data on 1,777,035 patients for the years 2006 to 2011 were acquired from the ACS NSQIP database. 9, 10 This database contains a nationwide data set representing cases from a wide range of academic and private hospitals across 47 US states. 14 Cases are analyzed for a predetermined collection of complications, including VTEs. Reviewers are frequently audited, and stringent criteria for each complication are used. In particular, DVTs must be diagnosed within 30 days of an operation by using duplex ultrasound, venography, or CT scanning, and patients must be treated for these clots with an inferior vena cava filter, inferior vena cava ligation, or anticoagulation therapy. Pulmonary embolisms must occur within 30 days of an operation and must be confirmed with a highprobability ventilation-perfusion (VQ) scan, CT scan, or pulmonary arteriogram.
Database files were acquired in delimited text format and parsed using both SPSS version 20 (IBM Corp.) and MATLAB R2012a (MathWorks Inc.). Neurosurgical cases were extracted by querying the data for which the surgical specialty was listed as "neurological surgery" and further classified as "spine" or "cranial" depending on the current procedural terminology (CPT) code (Table  1) . Descriptive statistics are represented as the means ± standard deviation. Univariate statistics were calculated using the chi-square test, and 95% confidence intervals are presented for the resultant risk ratios. Predictors included in the models are listed in Table 2 . Multivariate models were constructed using binary logistic regression with a maximum of 20 iterations. Variables that were significant (p < 0.05) on univariate analysis were included in the multivariate model. During model building, insignificant predictors (p > 0.05) were removed in a stepwise fashion using the Wald statistic. Significant predictors from this model were identified, and their odds ratios were presented along with the 95% confidence intervals.
Results

Demographics and Prevalence
Using the NSQIP database, we identified 38,058 neurosurgical cases for the years 2006 to 2011. Patient demographics are shown in Table 3 . Six hundred forty cases of VTE were identified, corresponding to 1.7% of the neurosurgical cases. Of these cases, 244 (0.6%) involved PEs and 484 (1.3%) involved DVTs requiring treatment. Asymptomatic and untreated DVTs were not included in this analysis. The prevalence of VTEs was consistent from year to year, ranging from a low of 0090T  21137  0092T  21139  0093T  21180  0095T  21299  0096T  35001-5  0163T  35201  0195T  35301  0196T  35800  0202T  37605  10121  37799  10140  49422  10180  60600  11000  61150-888  11042-4  62000-362  20005  69511  20100  20696  20902  20922  20930  20931  20936  20938  20999  21026  21501  21510  21610  21615  22010  22015  22100-14  22206-26  22318-27  22520-95  22600-32  22800-99  27080  27202  27218  27280  42725  49215  63001-308  63685  63700-41  64573-85 
Predictors of VTE
Multivariate statistical analysis was used to identify patient characteristics predictive of VTE, PE, and DVT formation. For VTEs (that is, DVTs requiring treatment and PEs), the rate of cranial cases was far higher than the rate of spinal cases (3.4% vs 1.1%; These individual predictors were also identified when constructing a multivariate model exclusively with DVTs (Table 5 ). However, three additional significant protective predictors were found: severe chronic obstructive pulmonary disease (COPD; OR 1.62, 95% CI 1.05-2.49), chemotherapy use (OR 2.16, 95% CI 1.20-3.88), and tobacco use (OR 0.70, 95% CI 0.51-0.96).
Because there were fewer PEs than DVTs (244 vs 484) and consequently less power in the statistical analysis, fewer significant predictors were identified in the analysis of PEs when examined in isolation (Table 6 ). Nevertheless, the type of procedure (cranial vs spinal) remained significant, as did the presence of paraparesis (OR 2.78, 95% CI 1.57-4.90) or SIRS (OR 2.69, 95% CI 1.56-4.63). One additional predictor, not found in the analysis of either VTEs or DVTs, was an altered mental status (OR 1.93, 95% CI 1.17-3.18). Again, these predictors were identified even when confounding variables, such as the presence of disseminated cancer or CNS tumors, were controlled for.
Discussion
Using the NSQIP database, which contains data from more than 1 million surgical patients, we analyzed patient-level predictors of VTE and, individually, of DVT and PE. Patients who underwent spine surgery were significantly less likely to develop DVTs or PEs than those who underwent cranial surgery, with an OR of 0.44 (95% CI 0.34-0.57). This was true even when accounting for multiple confounders using multivariate logistic regression (see Table 2 for a list of variables). The cause of this difference is unknown. Perhaps the NSQIP data set is lacking important predictors of VTE that would otherwise account for the discrepancy, although a great deal of variables are included, such as the presence of a CNS tumor, paralysis, stroke, coma, ventilator dependence, and so forth (Table  3) . Alternatively, physician practice could explain some of the difference. Perhaps cranial surgeons are less likely than spinal surgeons to prescribe VTE prophylaxis. If so, this tendency could be attributable to a heightened concern among cranial surgeons for postoperative bleeding and the devastating consequences thereof, despite the fact that multiple studies refute this idea. 1, 3, 5, 7, 12 It should be noted that the NSQIP database contains no information about whether thromboprophylaxis was used. A last possibility relates to follow-up time. Perhaps cranial patients are hospitalized longer and thus have more time for VTEs to present themselves in the hospital setting and to show up as complications within the medical record.
Other predictors of VTE identified in this study have been previously mentioned and thus offer validity to the methodology used herein. These predictors include the presence of cancer and venostasis, such as that found in the many forms of immobility documented in the NSQIP (quadriparesis, paralysis, hemiparesis, and ventilator dependence). 17 Perhaps less anticipated was steroid use as a risk factor. There is some evidence that steroid use is a risk factor for VTE in patients with Crohn's disease: In one study, 61.5% of patients on steroids developed portal venous thrombosis versus 28.9% of patients not on steroids.
11
This association with steroids is also supported by studies showing that patients with Cushing's disease have an elevated risk of VTE, presumably through a variety of increased procoagulant factors.
16
Another underappreciated risk factor identified in this study was sepsis, which has been illustrated outside the neurosurgical context. 15 There are a variety of proposed mechanisms for the observed increased thrombogenesis, including overproduction of plasminogen activator inhibitor-1, dysfunctional endothelial cells, and aberrant expression of tissue factor. 15 Further study of these pathways in neurosurgical patients may be warranted.
A number of limitations to our analysis are worth noting. The NSQIP database documents only VTEs that were symptomatic and required treatment, which probably results in an underrepresentation of the true incidence of VTE since asymptomatic events are not documented. In the same regard, patients with symptomatic VTE who had contraindications to treatment were also probably not included in the analysis. As the NSQIP database collects and tracks data across multiple surgical specialties, the comorbidities and risk adjustment variables that are tracked tend to be general and broad. The presence of cardiac, pulmonary, or endocrinological comorbidities are well documented, as are a number of procedural risk factors, such as whether a case was done in an emergent setting; however, these procedural risk factors are general and not specific to neurosurgery. For example, within spinal surgeries, a single-level laminotomy is included in the same analysis group as a multilevel deformity correction, and it is difficult to differentiate cases by complexity based on variables specific to neurosurgery (for example, levels performed for the same procedure). Another limitation is the lack of information regarding DVT prophylaxis, which is now used more frequently than in the past. The proportion of patients with sequential compression devices, subcutaneous heparin, or low-molecular-weight heparin is unknown, as is the degree to which these interventions lower the rates of VTEs in this patient population. It is our hope that future databases, such as the National Neurosurgery Quality and Outcomes Database (N 2 QOD), include this and other more granular data to better learn about VTE mitigation strategies and their potential risks in neurosurgical patients. 
Conclusions
Venous thromboembolism is a common complication in neurosurgical patients, having affected 1.7% of patients in the NSQIP database. Deep venous thromboses are roughly twice as common as PEs (1.3% vs 0.6%, respectively), and the rate of VTEs has not changed appreciably over the past several years. Many factors predictive of VTEs were identified in this population: ventilator dependence, immobility (as from quadriparesis, hemiparesis, or paraparesis), and malignancy. Less anticipated predictors included chronic steroid use and sepsis. Lastly, VTEs appear significantly more likely to occur in patients undergoing cranial procedures (3.4%) than in those undergoing spinal procedures (1.1%). The sources of this discrepancy are unknown but deserve more careful study. It is our hope that a better appreciation of the prevalence and risk factors of VTEs in neurosurgical patients will allow us to better target interventions and have a better understanding of which patients are most at risk. 
